MAUREEN DANGELO: Open Payments
NPI 1457668519 · ALLIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 83 payments from 14 companies in 2025. Trend: 2023 $71 · 2024 $362 · 2025 $1,349
Food & beverage: $1,264Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $494 |
| Janssen Biotech, Inc. | 10 | $223 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $165 |
| Ipsen Biopharmaceuticals, Inc | 4 | $86 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Gilead Sciences, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
Products named: TREMFYA, RINVOQ, XIFAXAN, CREON, LINZESS, IQIRVO, SKYRIZI, DUPIXENT.
Industry payments across OH — which companies pay providers there.
